Aadi Bioscience Stock Investor Sentiment

AADI Stock  USD 2.31  0.09  4.05%   
Under 58% of all Aadi Bioscience's traders are looking to take a long position. The analysis of the overall investor sentiment regarding Aadi Bioscience suggests that some traders are interested. Aadi Bioscience's investing sentiment shows overall attitude of investors towards Aadi Bioscience.
  

Aadi Bioscience Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Aadi Bioscience can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
over three months ago at www.macroaxis.com         
Disposition of 18933 shares by Neil Desai of Aadi Bioscience at 1.4105 subject to Rule 16b-3
Macroaxis News
over three months ago at www.macroaxis.com         
Disposition of 15415 shares by Neil Desai of Aadi Bioscience at 1.4956 subject to Rule 16b-3
Macroaxis News
over three months ago at finance.yahoo.com         
Were Keeping An Eye On Aadi Biosciences Cash Burn Rate
Yahoo News
over three months ago at finance.yahoo.com         
Aadi Bioscience to Report Second Quarter 2024 Results and Corporate Update
Yahoo News
over three months ago at news.google.com         
Aadi Bioscience, Inc. Sees Large Decline in Short Interest - Defense World
Google News at Macroaxis
over three months ago at www.macroaxis.com         
Acquisition by Delaney Brendan of 61000 shares of Aadi Bioscience subject to Rule 16b-3
Macroaxis News
over three months ago at news.google.com         
Aadi Bioscience, Inc. Sees Significant Drop in Short Interest - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
Aadi Bioscience, Inc. Sees Significant Drop in Short Interest - Defense World
Google News at Macroaxis
over three months ago at simplywall.st         
Lacklustre Performance Is Driving Aadi Bioscience, Inc.s 27 percent Price Drop
Simply Wall St News at Macroaxis
over three months ago at simplywall.st         
Will Aadi Bioscience Spend Its Cash Wisely?
Simply Wall St News at Macroaxis
over three months ago at simplywall.st         
Disposition of 8652 shares by Neil Desai of Aadi Bioscience at 1.3421 subject to Rule 16b-3
Simply Wall St News at Macroaxis
over three months ago at www.macroaxis.com         
Disposition of 31348 shares by Neil Desai of Aadi Bioscience at 1.4548 subject to Rule 16b-3
Macroaxis News
over three months ago at news.google.com         
Aadi Bioscience to Present at the 43rd Annual Cowen Healthcare Conference - Quantisnow
Google News at Macroaxis
over three months ago at news.google.com         
Aadi Bioscience Trading Up 3.7 percent - Defense World
Google News at Macroaxis
over three months ago at www.macroaxis.com         
Acquisition by Hehenberger Karin M. of 45832 shares of Aadi Bioscience at 1.7 subject to Rule 16b-3
Macroaxis News
Far too much social signal, news, headlines, and media speculation about Aadi Bioscience that are available to investors today. That information is available publicly through Aadi media outlets and privately through word of mouth or via Aadi internal channels. However, regardless of the origin, that massive amount of Aadi data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Aadi Bioscience news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Aadi Bioscience relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Aadi Bioscience's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Aadi Bioscience alpha.

Aadi Bioscience Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Disposition of 40000 shares by Neil Desai of Aadi Bioscience at 1.7079 subject to Rule 16b-3
09/03/2024
2
Disposition of 9583 shares by Neil Desai of Aadi Bioscience at 7.446 subject to Rule 16b-3
09/05/2024
3
Aadi Bioscience executive chairman sells shares worth over 68,000 - Investing.com
09/06/2024
4
Disposition of 32558 shares by David Lennon of Aadi Bioscience subject to Rule 16b-3
10/02/2024
5
Acquisition by Dalal Anupam of 18573 shares of Aadi Bioscience at 13.46 subject to Rule 16b-3
10/04/2024
6
Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update - Morningstar
10/30/2024
7
Aadi Bioscience Inc Q3 2024 Earnings Revenue Hits 7. ...
11/06/2024
8
BML Capital Management LLC Takes 4.12 Million Position in Aadi Bioscience, Inc. - MarketBeat
11/12/2024

Complementary Tools for Aadi Stock analysis

When running Aadi Bioscience's price analysis, check to measure Aadi Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aadi Bioscience is operating at the current time. Most of Aadi Bioscience's value examination focuses on studying past and present price action to predict the probability of Aadi Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aadi Bioscience's price. Additionally, you may evaluate how the addition of Aadi Bioscience to your portfolios can decrease your overall portfolio volatility.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments